Niusule Biotech Corporation increases ownership in Tianjin Behigh to 59%

Niusule Biotech Corporation announced today its acquisition of an additional 14% equity interest in Tianjin Behigh Pharmaceutical Co. Ltd.

Niusule Biotech Corporation is a China-based bio-pharmaceutical company with primary concentration on animal health products. Tianjin Behigh is an animal health company in business for more than 10 years.

Management believes that market demand for livestock products in China has been stimulated by the rapid urbanisation and increase in disposable income throughout the country. According to the "Veterinary Drugs Market Guide" published in 2009, the growth rate of the farming industry in China is 12-15%, which is more than that of developed countries.

he manufacturers of veterinary drugs should benefit directly from this market expansion. Management believes that the concern for safe, high quality, nutritional, and pollution-free green products has become the consensus of the consumers of veterinary products and is becoming the basic driving force for the development of the veterinary drugs industry.